Document ID: chunk:federal_register_of_legislation:F2013C00288:reg:6:p2
Version: federal_register_of_legislation:F2013C00288
Segment Type: reg
Provision Reference: reg 6 (pt 2/4)
Character Range: 2045700–2048907

compiled instrument is affected by an uncommenced amendment, the text of the uncommenced amendment is set out in the endnotes.

Application, saving and transitional provisions for amendments

If the operation of an amendment is affected by an application, saving or transitional provision, the provision is identified in the endnotes.

Modifications

If a provision of the compiled instrument is affected by a textual modification that is in force, the text of the modifying provision is set out in the endnotes.

Provisions ceasing to have effect

If a provision of the compiled instrument has expired or otherwise ceased to have effect in accordance with a provision of the instrument, details of the provision are set out in the endnotes.

  Page
1 Arsenic
1.1 General
1.2 Previous HIL
1.3 Significance of Exposure Pathways
1.3.1 Oral Bioavailability
1.3.2 Dermal Absorption
1.3.3 Inhalation of Dust
1.3.4 Plant Uptake
1.3.5 Intakes from Other Sources – Background
1.4 Identification of Toxicity Reference Values
1.4.1 Classification
1.4.2 Review of Oral Information
1.4.3 Assessment of End Points – Oral Exposures
1.4.3.1 Existing Oral DoseResponse Approaches  Australia
1.4.3.2 Oral DoseResponse Approaches - International
1.4.4 Inhalation Values
1.4.5 Recommendation
1.5 Calculated HILs
1.6 References
2 Beryllium
2.1 General
2.2 Previous HIL
2.3 Significance of Exposure Pathways
2.3.1 Oral Bioavailability
2.3.2 Dermal absorption
2.3.3 Inhalation of Dust
2.3.4 Plant Uptake
2.3.5 Intakes from Other Sources – Background
2.4 Identification of Toxicity Reference Values
2.4.1 Classification
2.4.2 Review of Available Values/Information
2.4.3 Recommendation
2.5 Calculated HILs
2.6 References
3 Boron
3.1 General
3.2 Previous HIL
3.3 Significance of Exposure Pathways
3.3.1 Oral Bioavailability
3.3.2 Dermal absorption
3.3.3 Inhalation of Dust
3.3.4 Plant Uptake
3.3.5 Intakes from Other Sources – Background
3.4 Identification of Toxicity Reference Values
3.4.1 Classification
3.4.2 Review of Available Values/Information
3.4.3 Recommendation
3.5 Calculated HILs
3.6 References
4 Cadmium
4.1 General
4.2 Previous HIL
4.3 Significance of Exposure Pathways
4.3.1 Oral Bioavailability
4.3.2 Dermal absorption
4.3.3 Inhalation of Dust
4.3.4 Plant Uptake
4.3.5 Intakes from Other Sources – Background
4.4 Identification of Toxicity Reference Values
4.4.1 Classification
4.4.2 Review of Available Values/Information
4.4.3 Oral (and Dermal) Intakes
4.4.4 Inhalation Exposures
4.4.5 Recommendation
4.5 Calculated HILs
4.6 References
5 Chromium VI
5.1 General
5.2 Previous HIL
5.3 Significance of Exposure Pathways
5.3.1 Oral Bioavailability
5.3.2 Dermal absorption
5.3.3 Inhalation of Dust
5.3.4 Plant Uptake
5.3.5 Intakes from Other Sources – Background
5.4 Identification of Toxicity Reference Values
5.4.1 Classification
5.4.2 Review of Available Values/Information
5.4.2.1 Oral Intakes
5.4.2.2 Inhalation Exposures
5.4.3 Recommendation
5.5 Calculated HILs
5.6 References
6 Cobalt
6.1 General
6.2 Previous HIL
6.3 Significance of Exposure Pathways
6.3.1 Oral Bioavailability
6.3.2 Dermal absorption
6.3.3 Inhalation of Dust
6.3.4 Plant Uptake
6.3.5 Intakes from Other Sources – Background
6.4